Results 11 to 20 of about 187,275 (304)

Assessment of adherence level of patients on anticoagulant therapy in a tertiary healthcare facility in Uyo, Nigeria

Ibom Medical Journal, 2021
Background: Anticoagulants are highly effective in preventing venous thromboembolism and remains the main stay of treatment. However, strict adherence to medication is essential for maximizing treatment. Objectives: the objectives of this study, were to
Ekwere TA, Ekanem AM, Benson SM
doaj   +1 more source

Anticoagulation after typical atrial flutter ablation [PDF]

Клиническая практика, 2023
The specifics of the anticoagulant therapy after radiofrequency ablation of the cavotricuspid isthmus have not been sufficiently studied, therefore, the recommendations for prescribing the anticoagulant therapy usually do not distinguish between atrial ...
Irina A. Bulavina, Igor A. Khamnagadaev, Igor I. Khamnagadaev, Mikhail L. Kokov, Aleksandr V. Troitskiy, Aleksandr S. Zotov, Leonid S. Kokov, Maria A. Shkolnikova   +7 more
doaj   +1 more source

Impact of Preinjury Antithrombotic Therapy on 30–Day Mortality in Older Patients Hospitalized With Traumatic Brain Injury (TBI)

Frontiers in Neurology, 2021
Objective: Elderly patients are frequently in need of antithrombotic therapy for reducing thrombotic events. The association between antithrombotic drugs and survival after traumatic brain injury (TBI) is, nevertheless, unclear.Methods: This ...
Pål Rønning, Eirik Helseth, Eirik Helseth, Ola Skaansar, Cathrine Tverdal, Cathrine Tverdal, Nada Andelic, Nada Andelic, Rahul Bhatnagar, Mathias Melberg, Nils Oddvar Skaga, Mads Aarhus, Sigrun Halvorsen, Sigrun Halvorsen, Ragnhild Helseth   +14 more
doaj   +1 more source

Anticoagulant therapy with fondaparinux in a liver transplant patient with thrombosis and liver fibrosis: a case report [PDF]

, 2017
The treatment with fondaparinux is the effective and safe anticoagulant therapy in liver transplant patient on immunosuppressive therapy with arterial thrombosis, and it seems able to reduce liver fibrosis.
Cafolla, Arturo, Gentile, Giuseppe
core   +1 more source

Factors influencing primary care physicians’ prescribing behavior of anticoagulant therapy for the management of patients with non-valvular atrial fibrillation in Singapore: a qualitative research study

BMC Family Practice, 2021
Background Oral anticoagulant therapy use in patients with atrial fibrillation (AF) remains suboptimal in Singapore, despite the availability of both warfarin and non-vitamin K antagonist oral anticoagulants (NOACs).
Shera Chaterji, Lay Geok Lian, Ting Yee Lee, Liwei Chua, Sabrina Yi-Mei Wee, Sui Ling Yap, Dhana Letchimy K, Ngiap Chuan Tan   +7 more
doaj   +1 more source

Anticoagulant Therapy in Moderate to Severe COVID-19 Patients

Mutiara Medika, 2022
Coronavirus disease-19 (COVID-19) has a spectrum of severity from no symptoms to serious complications. Coagulopathy is a serious complication of COVID-19, and that condition is a marker of poor prognosis.
Agus Fitriyanto Achmad, Yuni Iswati Raharjani, Zidni Setyaningrum, Bagus Andi Pramono, Dita Ria Selvyana, Sri Pramesthi Wisnu Bowo Negoro   +5 more
doaj   +1 more source

Anticoagulants for acute ischaemic stroke [PDF]

, 2015
Peer reviewedPublisher ...
Counsell, Carl, Kane, Edward J, Sandercock, Peter A G   +2 more
core   +1 more source

Anticoagulation Therapy

Hematology, 2001
Abstract Despite refinements and standardization in the use of anticoagulants, many problems remain for clinicians. Dr. Crowther describes appropriate starting and maintenance doses of warfarin, factors accounting for inter- and intra-observer variability and importantly, the management of the over-anticoagulated patients and bleeding ...
J A, Ginsberg, M A, Crowther, R H, White, T L, Ortel   +3 more
openaire   +2 more sources

Does antithrombotic therapy improve survival with colorectal cancer?

World Journal of Surgical Oncology, 2017
Background The study aimed to evaluate the prognosis for patients with colorectal cancer who underwent surgery while receiving antithrombotic therapy (ATT) across all disease stages and for patients at disease stages 0–III.
Kodai Takahashi, Hideto Ito, Masatoshi Hashimoto, Kazuhito Mita, Hideki Asakawa, Takashi Hayashi, Keiichi Fujino   +6 more
doaj   +1 more source

Clinical audit of anticoagulant therapy with pregnancy

Al-Azhar Assiut Medical Journal, 2020
Background and aim Anticoagulant use in pregnant women should be paid great attention in both the period of pregnancy and the postpartum period. Risks and benefits to the mother and fetus should be balanced in the choice of anticoagulant therapy ...
Mahmoud I El-Rasheedy, Ahmed H Mohammed, Asmaa M Mahmoud   +2 more
doaj   +1 more source